Industry professionals are invited to attend the KOL & Thought Leader Engagement Summit, hosted by Dynamic Global Events (“DGE”), a Life Science Leader in organizing B2B Events. The Global Event Company caters to the dynamic informational and networking needs of the Pharmaceutical, Biotechnology, Healthcare, Medical Devices, and allied industries.

The event timings on the first day are 8:30 am – 5:00 pm. The next day’s timings are 8:30 am – 4:15 pm, concluding the event with a discussion on the understanding of KOL Motivators and Expectations.

DGE’s two-day event will include presentations, and discussions from leading life science professionals on how to identify, engage, build, and nuture relationships with KOLs. The KOL & Thought Leadership Engagement Summit offers this unique opportunity to learn about regulations and identify the best strategies to stay in compliance when engaging with KOLs.

The key theme of the Engagement Summit revolves around the acquisition of medical and scientific information, along with transparent, compliant compensation for advisory board participation, in an environment where industry professionals are engaging traditional KOLs as well as new thought leaders.

The introductory speech will be given by Bryan N. Bischel, Ph.D. Medical Director, Hepatology at Mallinckrodt Pharmaceuticals, USA. Bryan is an accomplished senior medical affairs professional with more than 15 years of progressively responsible medical affairs experience. He is a strategic thinker and a results-driven leader with high emotional intelligence and skills to hire, train, and direct high-impact MSL teams.

Additional influential and respected speakers include:

• Jefferson Tea, VP, Medical and Scientific Affairs, TAKEDA Canada
• Alice Chung, Senior Manager, Strategic Analytics and Intelligence, Medical and Scientific Team, Genentech
• Christina Tankersley, Senior Director, MSLs, Sanofi Pasteur
• Alan Polnariev, Senior MSL, Nephrology, AstraZeneca
• Kevin Ryan, VP, Chief Compliance Offer, Acadia

KOL and Thought Leader Engagement professionals can leverage the event to:

• Gain knowledge from top experts on how to effectively engage with KOLs
• Identify best strategies to establish and maintain meaningful relationships with KOLs
• Learn about legal regulations and how to stay in compliance when engaging with KOLs
• Learn about different approaches and methodologies for identifying KOLs
• Examine the different platforms used to identify, track, and map KOLs

In these uncertain times of public fear and distrust, DGE’s premier KOL & Thought Leader Engagement Summit will help bridge between regulations, demand for new products, and cultivating KOL relationships that offer credibility to the products of the medical community.

To register for this event, please visit https://ibn.fm/IT1sy

To receive a discount on your registration, please use code IBN2021.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.